A Single-Arm, Expanded Access Study of Zanubrutinib (BGB3111) in Patients With B-cell Malignancies
Conditions: Mantle Cell Lymphoma; Waldenström Macroglobulinemia Intervention: Drug: Zanubrutinib Sponsor: BeiGene Available
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Lymphoma | Macroglobulinemia | Research | Study | Waldenstrom's Macroglobulinemia